MedTrace Logo

Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma

NCT03668158 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-10-24

No results posted yet for this study

Summary

The purpose of this study is to establish molecular subtyping of HCC.

Conditions

Sponsors & Collaborators

  • Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-20
Primary Completion
2020-05-01
Completion
2020-07-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03668158 on ClinicalTrials.gov